Ikarian-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
141
Total Value
710178588
Accession Number
0001420506-25-001276
Form Type
13F-HR
Manager Name
Ikarian-Capital
Data Enrichment
96% identified
135 identified6 unidentified

Holdings

141 positions
Manager:
Search and click to pin securities to the top
Page 5 of 8
Corvus Pharmaceuticals, Inc.
Shares:338.1K
Value:$1.1M
NEKTAR THERAPEUTICS
Shares:1.6M
Value:$1.1M
Tourmaline Bio, Inc.
Shares:67.9K
Value:$1.0M
Terns Pharmaceuticals, Inc.
Shares:308.5K
Value:$851.4K
Solid Biosciences Inc.
Shares:230.0K
Value:$851.0K
89bio, Inc.
Shares:100.0K
Value:$727.0K
Olema Pharmaceuticals, Inc.
Shares:192.0K
Value:$721.9K
VERU INC.
Shares:1.4M
Value:$698.5K
IMMUNIC, INC.
Shares:635.8K
Value:$693.0K
LEXICON PHARMACEUTICALS, INC.
Shares:1.4M
Value:$653.4K
Monte Rosa Therapeutics, Inc.
Shares:136.6K
Value:$633.7K
Channel Therapeutics Corp
Shares:440.8K
Value:$626.0K
Pyxis Oncology, Inc.
Shares:613.3K
Value:$600.9K
Disc Medicine, Inc.
Shares:11.9K
Value:$590.7K
Inhibrx Biosciences, Inc.
Shares:42.1K
Value:$589.3K
Fulcrum Therapeutics, Inc.
Shares:200.1K
Value:$576.3K
SpringWorks Therapeutics, Inc.
Shares:12.5K
Value:$552.5K
Mineralys Therapeutics, Inc.
Shares:34.3K
Value:$544.7K
Kezar Life Sciences, Inc.
Shares:106.9K
Value:$521.7K
BiomX Inc.
Shares:893.0K
Value:$496.2K